EPISODE · May 10, 2022 · 9 MIN
ADMPU: Loralie Langman, Ph.D., and Paul Jannetto, Ph.D.
from Answers from the Lab · host Mayo Clinic Laboratories
(00:32): Before we get started, will you two, please tell us a little bit about yourselves and your backgrounds.(01:38) Thank you, Dr. Langman, Dr. Jannetto, would you mind going next?(02:38): Will you guys just give us some content on urine drug testing and, and how this helps really manage patients with substance use disorders(04:05): Could you tell us about, uh, Mayo clinic's new addiction medicine profile and its benefits?(06:45): Thank you for that. What alternative tests are available and how do these compare to this new profile?(08:36): Great points in it, monumental profile for Mayo Clinic laboratories. Thank you for your time today to learn more about this topic or to learn how to order this profile at your institution, please visit www.mayocliniclabs.com.
What this episode covers
Loralie Langman, Ph.D., and Paul Jannetto, Ph.D., discuss Mayo Clinic Laboratories' new addiction rehabilitation monitoring profile, a comprehensive evaluation to help guide and monitor patients as part of their treatment and recovery. Geared toward managing patients with addiction to common substances, the profile tests for opioids, benzodiazepines, stimulants, barbiturates, cocaine, marijuana, ethanol, and nicotine. The inclusion of specimen validity testing and enhanced reports with interpretive comments enables a clear picture of a patient’s substance use.
NOW PLAYING
ADMPU: Loralie Langman, Ph.D., and Paul Jannetto, Ph.D.
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m